Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

US, China hike tariffs as trade row intensifies

Sep 24, 2018

BEIJING — China and the United States imposed new tariff hikes on each other's goods Monday and Beijing accused Washington of bullying, giving no sign of compromise in an intensifying battle over technology that is weighing on global economic growth. U.S. regulators went ahead with a planned 10 percent tax on a $200 billion list of 5,745 Chinese imports including bicycles and furniture. China's customs agency said it responded at noon by beginning to collect taxes of 5 or 10 percent on a $60 billion list of 5,207 American goods, from honey to industrial chemicals. The conflict stems from U.S....

Asian stocks follow Wall Street higher

Sep 24, 2018

BEIJING — Asian stocks rose Friday after Wall Street hit a new high and a survey showed Japanese manufacturing accelerating. KEEPING SCORE: Tokyo's Nikkei 225 rose 0.5 percent to 23,793.35 and Hong Kong's Hang Seng added 0.9 percent to 27,712.47. The Shanghai Composite Index climbed 0.3 percent, erasing earlier losses, to 2,737.27 while Sydney's S&P-ASX 200 advanced 0.6 percent to 6,204.40. Seoul's Kospi was up 0.2 percent at 2,327.87 and benchmarks in Taiwan and Southeast Asia rose. New Zealand declined. WALL STREET: The Dow Jones industrial average and Standard & Poor's 500 index set records as a wave of buying...

The Latest: S. Korean diva sings at North Korean volcano

Sep 24, 2018

SEOUL, South Korea — The Latest on the summit between North Korean leader Kim Jong Un and South Korean President Moon Jae-in (all times local): 8 p.m. A South Korean pop singer has belted out a beloved Korean folk song in front of North Korean leader Kim Jong Un and South Korean President Moon Jae-in at a crater lake atop a volcano North Korea considers as sacred. Singer Ali was among the South Koreans who joined the leaders on a trip to Mount Paektu on the North Korean-Chinese border hours before they returned home on Thursday after three days of...

Stocks up despite trade dispute, oil drops on Trump threat

Sep 24, 2018

SINGAPORE — European markets climbed Thursday following a mixed day in Asia, buoyed by hopes the U.S. and China will proceed with talks to tackle their escalating trade dispute. The price of oil dropped after U.S. President Donald Trump warned OPEC to ensure production increases, as they promised this summer. KEEPING SCORE: France's CAC 40 rose 0.8 percent to 5,440 and Germany's DAX gained 0.7 percent to 12,297. Britain's FTSE 100 rose 0.2 percent to 7,346. Wall Street was set for small gains on the open. Dow futures added 0.2 percent while the S&P 500 future rose 0.1 percent. ASIA'S...

Moon to carry private message from Kim Jong Un to Trump

Sep 24, 2018

SEOUL, South Korea — A beaming South Korean President Moon Jae-in returned home from a whirlwind three-day summit with North Korean leader Kim Jong Un on Thursday saying that Kim wants the U.S. secretary of state to visit Pyongyang soon for nuclear talks, and also hopes for a quick follow-up to his June summit with Donald Trump. Moon told reporters in Seoul that he will carry a private message from Kim for Trump on the nuclear standoff when he meets with the U.S. president in New York next week on the sidelines of the U.N. General Assembly session. Both Trump,...

Sign up now!